Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-024059
Filing Date
2015-03-09
Accepted
2015-03-09 16:09:12
Documents
1
Period of Report
2014-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4137
  Complete submission text file 0001209191-15-024059.txt   5546
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOKE PHARMA, INC. 12555 HIGH BLUFF DR., SUITE 385 SAN DIEGO CA 92130
Business Address
CARLSON MARILYN R. (Reporting) CIK: 0001592848 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36075 | Film No.: 15685293